Identification
- Summary
-
Cavia porcellus skinis an extract from Cavia porcellus skin used in allergy testing.
- Generic Name
- Cavia porcellus skin
- DrugBank Accession Number
- DB10416
- Background
-
Cavia porcellus skin or pelt is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
-
Allergenics
Allergen Extract - Synonyms
-
- Guinea pig skin extract
Pharmacology
- Indication
-
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning models
with evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets. - Contraindications & Blackbox Warnings
-
Avoid life-threatening adverse drug eventsImprove clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support. - Pharmacodynamics
-
Not Available
- Mechanism of action
- Not Available
- Absorption
-
Not Available
- Volume of distribution
-
Not Available
- Protein binding
-
Not Available
- Metabolism
- Not Available
- Route of elimination
-
Not Available
- Half-life
-
Not Available
- Clearance
-
Not Available
- Adverse Effects
-
Improve decision support & research outcomesWith structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data. - Toxicity
-
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
-
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
-
药物产品信息从10 +全球地区Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions. - Brand Name Prescription Products
-
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Cavia Porcellus Skin Injection, solution 0.05 g/1mL Percutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US 
Cavia Porcellus Skin Injection, solution 0.05 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US Cavia Porcellus Skin Injection, solution 0.10 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US Cavia Porcellus Skin Injection, solution 1000 [PNU]/1mL Intradermal ALK-Abello, Inc. 1965-01-01 Not applicable US Cavia Porcellus Skin Injection, solution 10000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US Guinea Pig Epithelia Solution 0.001 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Guinea Pig Epithelia Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Guinea Pig Epithelia Solution 10000 [PNU]/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Guinea Pig Epithelia Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Guinea Pig Epithelia Solution 20000 [PNU]/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US - Mixture Products
-
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Guinea Pig Hair and Epithelia Cavia porcellus skin(0.5 g/20mL)+Cavia porcellus hair(0.5 g/20mL) Injection, solution Percutaneous; Subcutaneous Allergy Laboratories, Inc. 1967-12-07 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- GM3H4U6QS8
- CAS number
- Not Available
References
Clinical Trials
- Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
-
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
-
Not Available
- Packagers
-
Not Available
- Dosage Forms
-
Form Route Strength Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.10 g/1mL Injection, solution Subcutaneous 10000 [PNU]/1mL Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 10000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Percutaneous; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53